Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy.
Hiromi IhoriyaHirotsugu YamamotoTaihei YamadaKohei TsukaharaKanae InoueTetsuya YumotoHiromichi NaitoAtsunori NakaoPublished in: Clinical case reports (2018)
Hyperammonemia is a rare adverse effect of 5-fluorouracil (5-FU) therapy, but can be very serious, even fatal. Physicians must be aware that hyperammonemic encephalopathy sometimes develops as an adverse event after 5-FU therapy.